Indianapolis In: Saxenda litigation | DrugsMonitor.com

Saxenda litigation information for residents of Indianapolis In. Mass tort overview, state-specific legal context, and confidential case review. Educational reference only.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., Indianapolis In